Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomas
Titel:
Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomas
Auteur:
Ghilardi, G. Chong, E.A. Svoboda, J. Wohlfarth, P. Nasta, S.D. Williamson, S. Landsburg, J.D. Gerson, J.N. Barta, S.K. Pajarillo, R. Myers, J. Chen, A.I. Schachter, L. Yelton, R. Ballard, H.J. Hodges Dwinal, A. Gier, S. Victoriano, D. Weber, E. Napier, E. Garfall, A. Porter, D.L. Jäger, U. Maziarz, R.T. Ruella, M. Schuster, S.J.